Patents by Inventor Nuria Carreras
Nuria Carreras has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20170071895Abstract: The present invention is an ophthalmic composition containing a relatively high concentration of olopatadine. The composition is typically an ophthalmic aqueous solution containing relatively high concentrations of olopatadine solubilized within the solution. The composition is preferably capable of providing enhanced relief from symptoms of ocular allergic conjunctivitis, particularly late phase symptoms of ocular allergic conjunctivitis.Type: ApplicationFiled: November 22, 2016Publication date: March 16, 2017Inventors: Daniel A. Gamache, Laman Alani, Malay Ghosh, Francisco Javier Galan, Nuria Carreras Perdiguer, Onkar N. Singh
-
Patent number: 9533053Abstract: The present invention is an ophthalmic composition containing a relatively high concentration of olopatadine. The composition is typically an ophthalmic aqueous solution containing relatively high concentrations of olopatadine solubilized within the solution. The composition is preferably capable of providing enhanced relief from symptoms of ocular allergic conjunctivitis, particularly late phase symptoms of ocular allergic conjunctivitis.Type: GrantFiled: June 13, 2014Date of Patent: January 3, 2017Assignee: Alcon Research, Ltd.Inventors: Daniel A. Gamache, Laman Alani, Malay Ghosh, Francisco Javier Galan, Nuria Carreras Perdiguer, Onkar N. Singh
-
Patent number: 9114168Abstract: Pharmaceutical compositions containing a fluoroquinolone antibiotic drug are disclosed. The compositions exhibit improved homogeneity, improved bioavailability, lower turbidity or a combination thereof. The composition can be use as otic or nasal compositions, but are particularly useful as ophthalmic compositions.Type: GrantFiled: January 18, 2013Date of Patent: August 25, 2015Assignee: Alcon Pharmacueticals Ltd.Inventors: Inmaculada Campins, Nuria Jiménez, Roman Vidal, Nuria Carreras, Carmen Martinez, Francisco Javier Galàn
-
Publication number: 20140296328Abstract: The present invention is an ophthalmic composition containing a relatively high concentration of olopatadine. The composition is typically an ophthalmic aqueous solution containing relatively high concentrations of olopatadine solubilized within the solution. The composition is preferably capable of providing enhanced relief from symptoms of ocular allergic conjunctivitis, particularly late phase symptoms of ocular allergic conjunctivitis.Type: ApplicationFiled: June 13, 2014Publication date: October 2, 2014Inventors: Daniel A. Gamache, Laman Alani, Malay Ghosh, Francisco Javier Galan, Nuria Carreras Perdiguer, Onkar N. Singh
-
Patent number: 8791154Abstract: The present invention is an ophthalmic composition containing a relatively high concentration of olopatadine. The composition is typically an ophthalmic aqueous solution containing relatively high concentrations of olopatadine solubilized within the solution. The composition is preferably capable of providing enhanced relief from symptoms of ocular allergic conjunctivitis, particularly late phase symptoms of ocular allergic conjunctivitis.Type: GrantFiled: May 18, 2012Date of Patent: July 29, 2014Assignee: Alcon Research, Ltd.Inventors: Daniel A. Gamache, Laman Alani, Malay Ghosh, Francisco Javier Galán, Núria Carreras Perdiguer, Onkar N. Singh
-
Patent number: 8722735Abstract: The present invention is directed to the provision of pharmaceutical compositions. The compositions include a therapeutic agent and a relatively low amount of surfactant for providing higher bioavailability of the therapeutic agent. The compositions are particularly desirable as ophthalmic compositions in which the therapeutic agent is a prostaglandin such as travoprost and the surfactant is a vegetable oil such as castor oil.Type: GrantFiled: October 4, 2011Date of Patent: May 13, 2014Assignee: Alcon Research, Ltd.Inventors: Bhagwati P. Kabra, Nuria Carreras, Mónica Cuchi, Francisco Javier Galán, Mridvika, Elena González Puig, Nuria Jiménez, Carmen Martinez
-
Patent number: 8450311Abstract: Pharmaceutical compositions containing a fluoroquinolone antibiotic drug are disclosed. The compositions exhibit improved homogeneity, improved bioavailability, lower turbidity or a combination thereof. The composition can be use as otic or nasal compositions, but are particularly useful as ophthalmic compositions.Type: GrantFiled: May 29, 2009Date of Patent: May 28, 2013Assignee: Novartis AGInventors: Inmaculada Campins, Nuria Jiménez, Roman Vidal, Nuria Carreras, Carmen Martinez, Francisco Javier Galán
-
Publication number: 20120295967Abstract: The present invention is an ophthalmic composition containing a relatively high concentration of olopatadine. The composition is typically an ophthalmic aqueous solution containing relatively high concentrations of olopatadine solubilized within the solution. The composition is preferably capable of providing enhanced relief from symptoms of ocular allergic conjunctivitis, particularly late phase symptoms of ocular allergic conjunctivitis.Type: ApplicationFiled: May 18, 2012Publication date: November 22, 2012Inventors: Daniel A. Gamache, Laman Alani, Malay Ghosh, Francisco Javier Galán, Núria Carreras Perdiguer, Onkar N. Singh
-
Publication number: 20120029073Abstract: The present invention is directed to the provision of pharmaceutical compositions. The compositions include a therapeutic agent and a relatively low amount of surfactant for providing higher bioavailability of the therapeutic agent. The compositions are particularly desirable as ophthalmic compositions in which the therapeutic agent is a prostaglandin such as travoprost and the surfactant is a vegetable oil such as castor oil.Type: ApplicationFiled: October 4, 2011Publication date: February 2, 2012Inventors: Bhagwati P. Kabra, Nuria Carreras, Mónica Cuchi, Francisco Javier Galán, Mridvika, Elena González Puig, Nuria Jiménez, Carmen Martinez
-
Publication number: 20090306128Abstract: Pharmaceutical compositions containing a fluoroquinolone antibiotic drug are disclosed. The compositions exhibit improved homogeneity, improved bioavailability, lower turbidity or a combination thereof. The composition can be use as otic or nasal compositions, but are particularly useful as ophthalmic compositions.Type: ApplicationFiled: May 29, 2009Publication date: December 10, 2009Inventors: Inmaculada Campins, Nuria Jimenez, Roman Vidal, Nuria Carreras, Carmen Martinez, Francisco Javier Galan
-
Publication number: 20090286826Abstract: The present invention is directed to pharmaceutical compositions, such as ophthalmic gels. The compositions typically include a carboxyvinyl polymer. A povidone polymer is also typically included to stabilize the carboxyvinyl polymer against agents or ingredients (e.g., therapeutic agent) that can otherwise cause instability to the carboxyvinyl polymer.Type: ApplicationFiled: May 12, 2009Publication date: November 19, 2009Inventors: Francisco Javier Galan, Nuria Jimenez, Nuria Carreras
-
Publication number: 20090234004Abstract: The present invention is directed to the provision of pharmaceutical compositions. The compositions include a therapeutic agent and a relatively low amount of surfactant for providing higher bioavailability of the therapeutic agent. The compositions are particularly desirable as ophthalmic compositions in which the therapeutic agent is a prostaglandin such as travoprost and the surfactant is a vegetable oil such as castor oil.Type: ApplicationFiled: March 13, 2009Publication date: September 17, 2009Inventors: Bhagwati P. Kabra, Nuria Carreras, Monica Cuchi, Francisco Javier Galan, Mridvika, Elena Gonzalez Puig, Nuria Jimenez, Carmen Martinez
-
Publication number: 20020035088Abstract: Topically administrable aqueous solution compositions containing tobramycin and xanthan gum are disclosed. The solution compositions contain a buffering agent and a pH-adjusting agent in an amount sufficient to achieve a pH above 7.8 in order to minimize or avoid compatibility problems between tobramycin and xanthan gum.Type: ApplicationFiled: July 11, 2001Publication date: March 21, 2002Applicant: Alcon Universal Ltd.Inventors: Nuria Carreras Perdiguer, Jose Alberto Vallet Mas, Gemma Torrella Cabello
-
Patent number: 6352978Abstract: Topically administrable aqueous solution compositions containing tobramycin and xanthan gum are disclosed. The solution compositions contain a buffering agent and a pH-adjusting agent in an amount sufficient to achieve a pH above 7.8 in order to minimize or avoid compatibility problems between tobramycin and xanthan gum.Type: GrantFiled: July 11, 2001Date of Patent: March 5, 2002Assignee: Alcon Universal Ltd.Inventors: Nuria Carreras Perdiguer, Jose Alberto Vallet Mas, Gemma Torrella Cabello
-
Publication number: 20020020636Abstract: A device for the delivery of unstable pharmaceutical preparations is disclosed. The device includes an upper container for receiving a first component of the preparation and a lower container for receiving a second component of the preparation. The first and second components are unstable when mixed. Advantageous preparations for use in the device are also disclosed.Type: ApplicationFiled: December 15, 2000Publication date: February 21, 2002Inventors: Michael Van Wie Bergamini, Jose Alberto Vallet Mas, Gemma Torrella Cabello, Nuria Carreras Perdiguer, David W. Stroman
-
Patent number: 5885491Abstract: Methods of increasing storage stability of lipidic nucleus nanocapsules comprising adding a monosaccharide cryoprotective agent into the aqueous dispersion of the nanocapsules while maintaining gentle stirring until the same dissolves totally. Afterwards, freezing said dispersion thus obtained at a temperature of not less than -40.degree. C. for about 2 to 4 hours, and the eliminating the water by heating progressively to a temperature of about 35.degree. C. at reduced pressure, whereby a stable lyophilized product is obtained. The obtained product can be conveniently reconstituted by adding water or a more complex aqueous solution thereto. The nanocapsules have use in medicine, pharmacy, cosmetics, chemical industry, agriculture, and veterinary science.Type: GrantFiled: July 24, 1997Date of Patent: March 23, 1999Assignee: Laboratorios Cusi, S.A.Inventors: Francisco Javier Galan Valdivia, Anna Coll Dachs, Nuria Carreras Perdiguer
-
Patent number: 5851452Abstract: The process comprises: (1) preparing a fine dispersion of droplets or particles which contain, or are formed, of a chemical or biologically active substance in a phase comprised of a solvent and a non solvent of the polymer forming the coating and, optionally, a surfactant or suspending agent; (2) preparing a phase which contains the coat-forming polymer dissolved in a miscible solvent in any relationship with the prior dispersion, (3) mixing both phases continuously while maintaining constant the relationship between the phases and the mixture volume, and simultaneously spraying the resultant mixture in an evaporation system with temperature and vacuum conditions which provide for the instantaneous evaporation of the solvent from the polymer, causing the deposition of the polymer around the particles or droplets. Applications to pharmacy, medicine, cosmetics, veterinary, chemical industry, agriculture are discussed.Type: GrantFiled: July 22, 1996Date of Patent: December 22, 1998Assignee: Laboratorios Cusi, S.A.Inventors: Jose Alberto Vallet Mas, Francisco Javier Galan Valdivia, Nuria Carreras Perdiguer
-
Patent number: 5698219Abstract: A pharmaceutical vehicle which is a nanoemulsion is formulated using 0.1-10 % (w/v) of an oil; 0.1-10% (w/v) of a non-ionic surface active agent; a maximum of 0.01% (w/v) of benzalkonium chloride; a drug or a precursor or active substance; and optionally, one or more of the following components; isotonizing agents, viscosity modifying agents, stabilizers, buffers and/or antioxidants. The vehicle is prepared by emulsification of an aqueous phase which contains a non-ionic surface active agent with an organic phase containing dissolved therein an oil and the drug, drug precursor or active substance in an organic water miscible solvent and then totally removing by evaporation the organic solvent and part of the water up to the final desired volume. The vehicle is especially useful in ophthalmic preparations used to treat eye disorders and diseases.Type: GrantFiled: July 31, 1995Date of Patent: December 16, 1997Assignee: Laboratorios Cusi, S.A.Inventors: Francisco Javier Galan Valdivia, Anna Coll Dachs, Nuria Carreras Perdiguer